Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Exenatide inhibits NF-B and attenuates ER stress in diabetic cardiomyocyte models
Freezing and canning of foods result in similar losses (22)
For those interested in accessing retatrutide through legitimate means, clinical trial participation may be an option
#Biotech #CellTherapy #Diabetes #DrugDevelopment #BiotechInnovation #HealthcareInnovation To view or add a comment, sign in Antibody Therapeutics (IF=4.5, Oxford University Press) Research Highlight - Targeting VCAM-1 for Vascular Inflammation Were highlighting a research article published in Antibody Therapeutics - Volume 8, Issue 4 (October 2025): Assessing the therapeutic potential of a panel of novel VCAM-1 antibodies using microfluidic and three-dimensional in vitro models of vascular inflammation Jessica Pickett, Lucia Zacchi, Binura Perera, YUAO WU, Hang Ta from Griffith University and The University of Queensland Vascular inflammation and leukocyte recruitment play central roles in the development of atherosclerosis
